In summary, a structure-guided exit vector hop enabled discovery of small molecule degraders that form higher affinity complexes, enabling demonstration of prolonged biomarker modulation and anti-tumour efficacy in vivo in a SMARCA4-deficient xenograft model. This evidence concerns the gene SMARCA4 and neoplasm.